Abstract:Macrolides, lincosamides, and streptogramin B (MLS) are structurally distinct molecules that are among the safest antibiotics for prophylactic use and for the treatment of bacterial infections. The family of e rythromycin r esistance m ethyltransferases (Erm) invariantly install either one or two methyl groups onto the N 6,6 -adenosine of 2058 nucleotide (m 6 A2058) of the bacterial 23S rRNA, leading to bacterial cross-resistance to all MLS antibiotics. Despite extensive structural studies on the mechanism of Erm-mediated MLS resistance, how the m 6 A epitranscriptomic mark affects ribosome function and bacterial physiology is not well understood. Here, we show that Staphylococcus aureus cells harboring m 6 A2058 ribosomes are outcompeted by cells carrying unmodified ribosomes during infections and are severely impaired in colonization in the absence of an unmodified counterpart. The competitive advantage of m 6 A2058 ribosomes is manifested only upon antibiotic challenge. Using ribosome profiling (Ribo-Seq) and a dual-fluorescence reporter to measure ribosome occupancy and translational fidelity, we found that specific genes involved in host interactions, metabolism, and information processing are disproportionally deregulated in mRNA translation. This dysregulation is linked to a substantial reduction in translational capacity and fidelity in m 6 A2058 ribosomes. These findings point to a general "inefficient translation" mechanism of trade-offs associated with multidrug-resistant ribosomes. The Erm rRNA methyltransferases are widespread among nosocomial and commensal Gram-negative and Gram-positive bacteria. Upon exposure to sublethal doses of macrolide antibiotics, the expression of erm genes is upregulated, and Erm enzymes exquisitely methylate the universally conserved A2058 nucleotide of 23S rRNA in the bacterial ribosomes (m 6 A2058 ribosomes). The m 6 A mark prevents binding of all three clinically important classes of antibiotics (macrolides, lincosamides and streptogramin B (MLS)). While the mechanism of MLS resistance has been studied extensively, how the methylation affects protein synthesis and bacterial fitness is less well understood. We show that human pathogenic Staphylococcus aureus cells bearing m 6 A2058 ribosomes are defective in colonizing animals and have inferior competitive fitness to cells carrying unmodified ribosomes. Global and targeted translation analyses revealed that m 6 A2058 ribosomes exhibit decreased overall translational efficiency. Our data add to a growing list of examples linking fitness cost to the acquisition of resistance genes.

Macrolide antibiotics allosterically predispose the ribosome for translation arrest.

Macrolide antibiotic interaction and resistance on the bacterial ribosome

Mechanism of inhibition of protein synthesis by macrolide and lincosamide antibiotics

Revisiting the mechanism of macrolide-antibiotic resistance mediated by ribosomal protein L22

The context of the ribosome binding site in mRNAs defines specificity of action of kasugamycin, an inhibitor of translation initiation

The SecM arrest peptide traps a pre-peptide bond formation state of the ribosome

Epitranscriptional m 6 A modification of rRNA negatively impacts translation and host colonization in Staphylococcus aureus

Negamycin Induces Translational Stalling and Miscoding by Binding to the Small Subunit Head Domain of the Escherichia Coli Ribosome.

Structural basis for the context-specific action of classic peptidyl transferase inhibitors

Alternative Mode of E-Site tRNA Binding in the Presence of a Downstream mRNA Stem Loop at the Entrance Channel

Structural basis for the context-specific action of the classic peptidyl transferase inhibitor chloramphenicol

SecM leader peptide as an allosteric translation inhibitor: a molecular dynamics study

Translation inhibitors stabilize Escherichia coli mRNAs independently of ribosome protection

Structure of Dirithromycin Bound to the Bacterial Ribosome Suggests New Ways for Rational Improvement of Macrolides

Mechanisms of ribosome stalling by SecM at multiple elongation steps.

Ribosome-targeting antibiotics and mechanisms of bacterial resistance

From Erythromycin to Azithromycin and New Potential Ribosome-Binding Antimicrobials

Translational Control by Ribosome Pausing in Bacteria: How a Non-uniform Pace of Translation Affects Protein Production and Folding

Elongation factor P controls ribosomal frameshift of a antimicrobial resistance gene

Mechanistic Insights into Clinically Relevant Ribosome-Targeting Antibiotics

Structure-Activity Relationships and Mechanism of Action of Macrolides Derived from Erythromycin as Antibacterial Agents